rs1371203
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_005235.3(ERBB4):c.422-31062C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.773 in 151,942 control chromosomes in the GnomAD database, including 45,555 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.77 ( 45555 hom., cov: 32)
Consequence
ERBB4
NM_005235.3 intron
NM_005235.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.108
Publications
6 publications found
Genes affected
ERBB4 (HGNC:3432): (erb-b2 receptor tyrosine kinase 4) This gene is a member of the Tyr protein kinase family and the epidermal growth factor receptor subfamily. It encodes a single-pass type I membrane protein with multiple cysteine rich domains, a transmembrane domain, a tyrosine kinase domain, a phosphotidylinositol-3 kinase binding site and a PDZ domain binding motif. The protein binds to and is activated by neuregulins and other factors and induces a variety of cellular responses including mitogenesis and differentiation. Multiple proteolytic events allow for the release of a cytoplasmic fragment and an extracellular fragment. Mutations in this gene have been associated with cancer. Alternatively spliced variants which encode different protein isoforms have been described; however, not all variants have been fully characterized. [provided by RefSeq, Jul 2008]
ERBB4 Gene-Disease associations (from GenCC):
- amyotrophic lateral sclerosis type 19Inheritance: AD Classification: STRONG, MODERATE, LIMITED Submitted by: ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- amyotrophic lateral sclerosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.79 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.773 AC: 117417AN: 151822Hom.: 45555 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
117417
AN:
151822
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.773 AC: 117460AN: 151942Hom.: 45555 Cov.: 32 AF XY: 0.773 AC XY: 57392AN XY: 74260 show subpopulations
GnomAD4 genome
AF:
AC:
117460
AN:
151942
Hom.:
Cov.:
32
AF XY:
AC XY:
57392
AN XY:
74260
show subpopulations
African (AFR)
AF:
AC:
30741
AN:
41462
American (AMR)
AF:
AC:
11565
AN:
15240
Ashkenazi Jewish (ASJ)
AF:
AC:
2289
AN:
3472
East Asian (EAS)
AF:
AC:
3807
AN:
5174
South Asian (SAS)
AF:
AC:
3660
AN:
4812
European-Finnish (FIN)
AF:
AC:
8761
AN:
10564
Middle Eastern (MID)
AF:
AC:
221
AN:
292
European-Non Finnish (NFE)
AF:
AC:
54007
AN:
67900
Other (OTH)
AF:
AC:
1640
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1402
2805
4207
5610
7012
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2469
AN:
3468
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.